Understanding Why Some Recombinant Proteins Are Not Tested for Biological Activity

Abstract

Recombinant proteins are widely used in biotechnology, diagnostics, structural biology, and pharmaceutical research. While enzymatic or functional activity is desirable for many applications, not all recombinant protein products undergo activity testing. This paper discusses the major reasons why activity testing may not be feasible or necessary, highlights suitable experimental alternatives for untested proteins, addresses common problems associated with non-functional proteins, and provides key precautions for their proper use. A clear understanding of protein biology, expression systems, and intended application is essential to interpret recombinant protein utility accurately.

Introduction

Recombinant protein production has transformed modern bioscience by enabling large-scale synthesis of proteins in heterologous systems. These proteins serve diverse roles—from enzymes and antibodies to cytokines and receptors. However, a considerable number of recombinant protein products available commercially or produced in research labs are not validated for their biological or enzymatic activity. While this may appear limiting, it reflects practical, technical, and biological constraints. Importantly, many applications do not require fully active proteins, and suitable experimental approaches exist for their characterization and use.

Reasons Why Recombinant Proteins May Not Be Tested for Activity

1. The Protein Is Not Catalytically Active by Nature

Many recombinant proteins are not enzymes or active receptors. These include:

• Structural proteins 

• Ligands 

• Antigens used for antibody production or detection
  These proteins serve their roles through interactions or immune recognition, not through catalysis or signal transduction.

2. Expression in Non-Native Systems

Proteins expressed in systems such as Escherichia coli may:

• Lack proper post-translational modifications (e.g., glycosylation, phosphorylation)

• Fail to form correct disulfide bonds

• Be expressed in inclusion bodies, requiring difficult and sometimes unsuccessful refolding
  These factors can impair the protein's biological activity even if its sequence is correct.

3. Cofactor or Chaperone Dependency

Some proteins require:

• Metal ions (e.g., Mg²⁺, Zn²⁺, Mn²⁺)

• Coenzymes (e.g., NAD⁺, FAD, ATP)

• Partner proteins or membranes (e.g., GPCRs, kinases)
  When these are absent in the expression system or assay, activity may not manifest or be measurable.

4. Lack of Standardized Activity Assays

• Some proteins have complex biological roles or context-dependent functions.

• Validated assays may not exist or may require cell-based or in vivo models.

• Assay development for each product can be resource-intensive and time-consuming.

5. Intended Use Does Not Require Activity

Activity testing is unnecessary when proteins are used for:

• ELISA coating antigens

• Antibody screening and validation

• Vaccine development (non-live)

• Epitope mapping
  In such cases, conformational or linear epitope integrity is more important than functional activity.

Suitable Experiments for Untested Recombinant Proteins

While enzymatic or biological activity may not be validated, several assays can confirm identity, structural integrity, and interaction properties:

Common Problems with Non-Validated Proteins

1.Loss of activity due to aggregation or misfolding

2.Low solubility or precipitation under assay conditions

3.Inconsistent lot-to-lot performance

4.Batch degradation due to improper storage

5.Erroneous assumptions about function based solely on sequence

Precautions When Using Recombinant Proteins Not Tested for Activity

• Do not assume functional equivalence: Sequence identity does not guarantee biological activity.

• Read datasheets carefully: Look for disclaimers about activity testing.

• Confirm physical properties: Perform SDS-PAGE or size-exclusion chromatography to confirm purity and aggregation state.

• Validate function in your system: If function is critical, perform an in-house pilot assay or use a known positive control.

• Ensure storage stability: Follow storage and reconstitution instructions strictly to avoid loss of structural integrity.

Summary

While functional validation is ideal, many recombinant proteins are not tested for biological activity due to technical, biological, or economic constraints. Many such proteins are still highly valuable in applications such as structural biology, antibody development, or diagnostics. Researchers should evaluate protein function based on their specific experimental needs and use proper validation and controls. Clear documentation from suppliers and an understanding of the protein's biological context are critical to ensuring successful application.

References

1. Berlec, A., & Strukelj, B. (2013). Current state and recent advances in biopharmaceutical production in E. coli, yeasts and mammalian cells. Journal of Industrial Microbiology & Biotechnology, 40(3–4), 257–274.

2. Wingfield, P. T. (2015). Overview of the purification of recombinant proteins. Current Protocols in Protein Science, 80(1), 6.1.1–6.1.35.

3. Makino, T., Skretas, G., & Georgiou, G. (2011). Strain engineering for improved expression of recombinant proteins in bacteria. Microbial Cell Factories, 10(1), 32.

4. Scopes, R. K. (1994). Protein Purification: Principles and Practice (3rd ed.). Springer.

5. Walsh, G. (2014). Biopharmaceutical benchmarks 2014. Nature Biotechnology, 32(10), 992–1000.